hotspot -WSS

hotspot

author：hotspot 2025-10-02 17:23:04 - browse：549

Photo illustration of the FDA US Food and Drug website. -- health policy coverage from STAT — Adobe

WASHINGTON — Food and Drug Administration officials hope to finish this year a massive overhaul of the way the agency inspects facilities that make drugs, medical devices, and food products, they said Friday.

The reorganization was spurred by the FDA’s mishandling of the infant formula crisis. The agency was slow to inspect a major infant formula plant despite a whistleblower complaint about deadly bacterial contamination at the facility. An investigation found that the delayed response was due in part to the agency’s organization. A nonprofit, nonpartisan advisory body reported in December it was not clear who is in charge of food oversight, and agency food safety staff are siloed among divisions that don’t communicate with each other.

Although the food center has been the focus of attention in the reorganization, it will affect a huge swath of the agency. The reorganization is expected to impact about 8,000 FDA employees, according to Michael Rogers, FDA associate commissioner for regulatory affairs. The Office of Regulatory Affairs, which will be called the Office of Inspections and Investigations under the proposed reorganization, will go from having about 5,100 full-time employees to 3,586 employees.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Feng Zhang, Grail founder join forces on new gene editing startup

explore

WSS

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

New brain studies show LSD's effects on the brain in full color

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

NIH director takes cautious approach to Biden drug pricing priority

Readout Newsletter: Merck, J&J, and long Covid

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

hotspot

hotspot

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

Why doctors need education on FDA device approval process

Activists slam private health insurers over coverage restrictions

Goldman Sachs launches $650M fund for life science investments

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The FDA must approve intranasal treatments for anaphylaxis

Peter Hotez and the public health issue of online harassment

JPM: CVS says Medicare Advantage patients are impacting profits

After affirmative action ruling, medical educators look to 'holistic review'

The surgeon had a dilemma only a Nazi medical text could resolve

entertainment

How a scoliosis diagnosis changed the life of one young dancer

Dewpoint Therapeutics lays off staff after losing partnerships

Eli Lilly, Pfizer, and others want in on the online prescription market

GSK Flovent asthma inhalers replaced by authorized generics

The tragedy of Johnson & Johnson’s Covid vaccine

JPM: CVS says Medicare Advantage patients are impacting profits

Wikipedia

hotspot

explore

leisure time